![]() |
![]() |
![]() |
![]() |
||
![]() |
||
![]() |
![]() |
![]() |
![]() |
||
|
|
||
![]() |
||
![]() |
![]() |
![]() |
![]() |
||
![]() |
||
This article is from the Chronic Fatigue Syndrome (CFS) FAQ, by cfs-news@cais.com (Roger Burns) with numerous contributions by others.
There is a great deal of research going on, regarding the possible
cause of CFS, many of its symptom mechanisms, possible biological
markers, treatments, and epidemiology.
Dr. Mark Demitrack (U. Michigan) and Dr. Stephen Straus (NIH) and
others are studying the dysfunction of the
hypothalamic-pituitary-adrenal axis as being a possible major
explanation for CFS. Prof. Robert Suhadolnik (Temple U., Philadelphia)
is exploring a possible bio-marker for CFS found in patients'
blood. Drs. Hugh Dunstan and Timothy Roberts (U. Newcastle, Australia)
are researching a possible biological marker found in urine. Dr. Peter
Rowe (Johns Hopkins) is studying the possible link between CFS and
neurally mediated hypotension. Dr. Anthony Komaroff (Harvard) and
Dr. Dharam Ablashi (Georgetown) are researching the possible roles of
HHV-6 and EBV (to decipher these abbreviations, see Appendix
3). Drs. Andrew Lloyd, Ian Hickie, Denis Wakefield and Andrew Wilson
(Sydney, Australia) aremaking broad investigations into many aspect of
CFS. Dr. W. John Martin (U. So. Calif.) is studying the "Stealth"
virus. Dr. Michael Holmes (U. Otago) is researching another
mysterious, virus-like particle. Drs. Nancy Klimas, Roberto Patarca
(of U. Miami) and Jay Levy (UCSF) are investigating immunological
abnormalities. Drs. Paul Cheney, Charles Lapp and Jay Goldstein are
studying various treatments. Drs. Simon Wessely, Michael Sharpe and
other British psychiatrists are exploring the value of cognitive
behavior therapy for CFS. The CDC team led by Drs. Keiji Fukuda and
William Reeves are undertaking prevalence studies in the USA. These
are just a few of the more prominent studies now on-going.
 
Continue to:
![]() |
|
|